MedPath

Arkansas State University

Arkansas State University logo
🇺🇸United States
Ownership
Private
Established
1909-01-01
Employees
251
Market Cap
-
Website
http://www.astate.edu

Use of Modafinil in the Treatment of Tinnitus

Phase 1
Terminated
Conditions
Tinnitus
Interventions
Other: Placebo
First Posted Date
2008-01-11
Last Posted Date
2015-10-08
Lead Sponsor
University of Arkansas
Target Recruit Count
7
Registration Number
NCT00591019
Locations
🇺🇸

University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

Use of Breast MRI for Local Staging

Withdrawn
Conditions
Breast Cancer
First Posted Date
2007-12-24
Last Posted Date
2015-03-04
Lead Sponsor
University of Arkansas
Registration Number
NCT00579319

UARK 89-001 Phase II Study of Intensive "TOTAL THERAPY" For Untreated or Minimally Treated Patients With Multiple Myeloma

Phase 2
Completed
Conditions
Multiple Myeloma
Interventions
Drug: VAD
Procedure: Hemopoietic stem cell procurement
Drug: EDAP
Procedure: Autologous Hemopoietic Stem Cell Transplant 1
Procedure: Autologous Hemopoietic Stem Cell Transplant 2
Drug: Maintenance
First Posted Date
2007-12-24
Last Posted Date
2016-09-20
Lead Sponsor
University of Arkansas
Target Recruit Count
231
Registration Number
NCT00580372
Locations
🇺🇸

University of Arkansas for Medical Sciences/MIRT, Little Rock, Arkansas, United States

Real-Time Internet Evaluation of Swallowing

Completed
Conditions
Stroke
Head and Neck Cancer
First Posted Date
2007-12-24
Last Posted Date
2017-02-20
Lead Sponsor
University of Arkansas
Target Recruit Count
30
Registration Number
NCT00580138
Locations
🇺🇸

University of Wisconsin, Madison, Wisconsin, United States

🇺🇸

University of Illinois, Urbana-Champaign, Illinois, United States

Regulation of Cerebral Blood Flow in Very Low Birth Weight Infants

Completed
Conditions
Infant, Very Low Birth Weight
Infant, Premature, Diseases
Cerebral Hemorrhage
First Posted Date
2007-12-24
Last Posted Date
2008-06-04
Lead Sponsor
University of Arkansas
Target Recruit Count
200
Registration Number
NCT00579943
Locations
🇺🇸

University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

Histologic Diagnoses of Incidentally Detected Lesions on MRI

Withdrawn
Conditions
Breast Cancer
First Posted Date
2007-12-24
Last Posted Date
2015-03-04
Lead Sponsor
University of Arkansas
Registration Number
NCT00579735

2006-32 Phase II Study of Rapidly Recycled High Dose DTPACE

Phase 2
Completed
Conditions
Multiple Myeloma
Interventions
Drug: DTPACE
First Posted Date
2007-12-20
Last Posted Date
2017-11-20
Lead Sponsor
University of Arkansas
Target Recruit Count
4
Registration Number
NCT00577512
Locations
🇺🇸

University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

Diagnosis of Hemangiomas and Vascular Malformations

Completed
Conditions
Hemangiomas
Vascular Malformations
Venular Malformations
Venous Malformations
Lymphatic Malformations
Arteriovenous Malformations
First Posted Date
2007-12-20
Last Posted Date
2012-10-26
Lead Sponsor
University of Arkansas
Target Recruit Count
56
Registration Number
NCT00577213

A Pilot Study of the Combination of Melphalan, Bortezomib, Thalidomide and Dexamethasone (MEL-VTD)

Phase 2
Withdrawn
Conditions
Multiple Myeloma
Interventions
First Posted Date
2007-12-20
Last Posted Date
2011-05-03
Lead Sponsor
University of Arkansas
Registration Number
NCT00577668
Locations
🇺🇸

University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

UARK 2006-28 Human Cord Blood Transplantation in Advanced Hematological Malignancies

Phase 1
Withdrawn
Conditions
Multiple Myeloma
Interventions
Procedure: Transfusion
First Posted Date
2007-12-20
Last Posted Date
2015-10-26
Lead Sponsor
University of Arkansas
Registration Number
NCT00578045
Locations
🇺🇸

University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

© Copyright 2025. All Rights Reserved by MedPath